Allarity Therapeutics, Inc. Share Price
NASDAQ: ALLR | Micro CapAllarity Therapeutics, Inc. Stock Performance
Open $1.40 | Prev. Close $1.36 | Circuit Range N/A |
Day Range $1.35 - $1.40 | Year Range $0.78 - $2.30 | Volume 1,274 |
Average Traded $1.37 |
Allarity Therapeutics, Inc. Share Price Today
As of 10 August 2026, Allarity Therapeutics, Inc.'s share price is $1.39. The stock opened at $1.40, compared to its previous close of $1.36. During today's trading session, Allarity Therapeutics, Inc.'s share price traded between $1.35 and $1.40, with an average price of $1.38. Over the past 52 weeks, the stock has recorded a high of $2.30 and a low of $0.78. In terms of performance, Allarity Therapeutics, Inc.'s share price has risen by 40.04% over the last six months and is down 11.50% on a year-on-year basis.
Allarity Therapeutics, Inc. Share Price Chart
Allarity Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $19.91M | PE Ratio (TTM) -1.78 | Dividend Yield N/A |
EPS (TTM) $-0.78 | Revenue (TTM) $320000.00 | Return On Equity (TTM) -114.28% |
Profit Margin -3509.69% | Debt to Equity 0.86 | Quarterly Earnings Growth YoY 75.79% |
Allarity Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Allarity Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2 clinical trial in patients with advanced and recurrent ovarian cancer. The company also develops stenoparib- DRP, a companion diagnostic product used in select patients for stenoparib treatment. Allarity Therapeutics, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Allarity Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.24 | $1.38 | +12.20% |
Jul 2026 | $1.28 | $1.23 | -4.65% |
Jun 2026 | $1.56 | $1.29 | -22.29% |
May 2026 | $1.32 | $1.66 | +22.06% |
Apr 2026 | $1.12 | $1.36 | +24.77% |
Mar 2026 | $0.98 | $1.09 | +10.21% |
Feb 2026 | $0.94 | $0.99 | -3.04% |
Jan 2026 | $1.10 | $1.02 | -1.92% |
Dec 2025 | $1.29 | $1.04 | -20.61% |
Nov 2025 | $1.40 | $1.31 | -9.66% |
Oct 2025 | $1.58 | $1.45 | -7.05% |
Sep 2025 | $1.51 | $1.56 | -0.32% |